About this trial

The purpose of this study is to compare change in pelvic floor symptoms between patients receiving medical therapy for weight loss and surgical treatment for weight loss. Examples of pelvic floor symptoms include urinary incontinence, urinary urgency, urinary frequency, fecal incontinence, and vaginal prolapse. Participants in this study do not need to have any pelvic floor symptoms to enroll in the study. Understanding how different types of weight loss treatment impact pelvic floor symptoms will help clinicians guide which weight loss treatments are recommended for patients with pelvic floor symptoms in the future.

Eligibility criteria

Qualifiers

female

18-89 years old

any race/ethnicity

BMI ≥30 kg/m2

Disqualifiers

Pregnant

≥90 years old

<18 years old

BMI <30 kg/m2

Trial design

Treatments tested in this trial

  • Bariatric Surgery
  • GLP1 receptor agonist

Treatment groups

200 Participants
are divided into 2 treatment groups

Locations

1
Hartford Hospital06106, HartfordConnecticut, United States

Sponsors and collaborators

Hartford HealthCare

Lead sponsor